Patent Assignment
Reel/Frame 046703/0595
ENTITY CONVERSION
Recorded: 2018-08-03
Received: 2018-08-03
Pages: 7
Assignor
IMPAX LABORATORIES, INC.
Executed: 2018-05-04
Assignee
IMPAX LABORATORIES, LLC
30831 HUNTWOOD AVENUE, HAYWARD, CA, 94544, UNITED STATES
Covered Applications
(13)
CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF
App. No. 15/382,851
→
RAPIDLY DISINTEGRATING FORMULATIONS AND METHODS THEREOF
App. No. 15/035,272
→
MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF
App. No. 15/092,086
→
MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF
App. No. 15/027,654
→
CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF
App. No. 14/958,975
→
CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF
App. No. 14/030,792
→
CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF
App. No. 14/030,813
→
CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF
App. No. 13/900,408
→
CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF
App. No. 13/711,248
→
CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF
App. No. 13/367,230
→
CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF
App. No. 12/599,668
→
PHARMACEUTICAL DOSAGE FORMS HAVING IMMEDIATE RELEASE AND/OR CONTROLLED RELEASE PROPERTIES
App. No. 11/239,249
→
PRESS COATED, PULSATILE DRUG DELIVERY SYSTEM SUITABLE FOR ORAL ADMINISTRATION
App. No. 10/122,410
→